Novavax, Inc.

NASDAQ: NVAX
$80.71
-$6.92 (-7.9%)
Closing price October 30, 2020
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of where we stand with a coronavirus vaccine.
The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of a Phase 3 trial.
The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead of the others. Before getting into an actual prediction basis for knowing which vaccine (or...
America and the rest of the world is getting ready for a vaccine that will help protect public health against the COVID-19 pandemic. The societal impact of the coronavirus has changed many lives, and...
Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but none are approved yet.
Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair and Zynga.
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
Wednesday's top analyst upgrades and downgrades included Activision Blizzard, AON, Enphase Energy, Monster Beverage, New Relic, Novavax, Paycom, Walt Disney and Wynn Resorts.
The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street has picked out a few of the best and brightest that could still see a big...
Thursday's top analyst upgrades and downgrades included Cisco Systems, Dell Technologies, Dollar Tree, Hubspot, Jabil, Kraft Heinz, Novavax, Peloton Interactive, Shopify and Walt Disney.
Wednesday's top analyst upgrades and downgrades included Altria, Apple, Caterpillar, Citigroup, JPMorgan, Nikola, Nokia, Novavax, Transocean, Valero Energy, Walt Disney and Wells Fargo.
Novavax and Regeneron Pharmaceuticals each made solid progress on Tuesday after each company received a sizable capital injection from the U.S. government’s Operation Warp Speed program.
Here is a look of a few of the biggest clinical trial and FDA updates to watch for in July 2020.
Friday's top analyst upgrades and downgrades included Darden Restaurants, DuPont, EOG Resources, Lululemon Athletica, Micron Technology, Occidental Petroleum, Slack, Spotify, Ulta Beauty and Walt...